These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37129833)

  • 1. The EURO-FORTA (Fit fOR The Aged) List Version 2: Consensus Validation of a Clinical Tool for Improved Pharmacotherapy in Older Adults.
    Pazan F; Weiss C; Wehling M;
    Drugs Aging; 2023 May; 40(5):417-426. PubMed ID: 37129833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People.
    Pazan F; Weiss C; Wehling M;
    Drugs Aging; 2018 Jan; 35(1):61-71. PubMed ID: 29335932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The U.S.-FORTA (Fit fOR The Aged) List: Consensus Validation of a Clinical Tool to Improve Drug Therapy in Older Adults.
    Pazan F; Gercke Y; Weiss C; Wehling M;
    J Am Med Dir Assoc; 2020 Mar; 21(3):439.e9-439.e13. PubMed ID: 31542300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The JAPAN-FORTA (Fit fOR The Aged) list: Consensus validation of a clinical tool to improve drug therapy in older adults.
    Pazan F; Gercke Y; Weiss C; Wehling M;
    Arch Gerontol Geriatr; 2020; 91():104217. PubMed ID: 32791361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus validation of the FORTA (Fit fOR The Aged) List: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly.
    Kuhn-Thiel AM; Weiß C; Wehling M;
    Drugs Aging; 2014 Feb; 31(2):131-40. PubMed ID: 24353033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The FORTA (Fit fOR The Aged) List].
    Pazan F; Wehling M
    Inn Med (Heidelb); 2024 Jan; 65(1):3-8. PubMed ID: 38063911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FORTA (Fit fOR The Aged)-EPI (Epidemiological) Algorithm: Application of an Information Technology Tool for the Epidemiological Assessment of Drug Treatment in Older People.
    Rabenberg A; Schulte T; Hildebrandt H; Wehling M
    Drugs Aging; 2019 Oct; 36(10):969-978. PubMed ID: 31435913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge on and use of the FORTA ("Fit fOR The Aged")-list and the FORTA App by general practitioners in Baden-Württemberg, Germany.
    Meyer L; Wehling M
    Eur Geriatr Med; 2020 Jun; 11(3):499-503. PubMed ID: 32297266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries.
    Renom-Guiteras A; Meyer G; Thürmann PA
    Eur J Clin Pharmacol; 2015 Jul; 71(7):861-75. PubMed ID: 25967540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification.
    Wehling M; Burkhardt H; Kuhn-Thiel A; Pazan F; Throm C; Weiss C; Frohnhofen H
    Age Ageing; 2016 Mar; 45(2):262-7. PubMed ID: 26786346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Structured Literature Review and International Consensus Validation of FORTA Labels of Oral Anticoagulants for Long-Term Treatment of Atrial Fibrillation in Older Patients (OAC-FORTA 2019).
    Pazan F; Collins R; Gil VM; Hanon O; Hardt R; Hoffmeister M; Monteiro P; Quinn TJ; Ropers D; Sergi G; Verheugt FWA; Wehling M
    Drugs Aging; 2020 Jul; 37(7):539-548. PubMed ID: 32500503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriateness of Oral Anticoagulants for the Long-Term Treatment of Atrial Fibrillation in Older People: Results of an Evidence-Based Review and International Consensus Validation Process (OAC-FORTA 2016).
    Wehling M; Collins R; Gil VM; Hanon O; Hardt R; Hoffmeister M; Monteiro P; Quinn TJ; Ropers D; Sergi G; Verheugt FWA
    Drugs Aging; 2017 Jul; 34(7):499-507. PubMed ID: 28493216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in prescription patterns in older hospitalized patients: the impact of FORTA on disease-related over- and under-treatments.
    Pazan F; Burkhardt H; Frohnhofen H; Weiss C; Throm C; Kuhn-Thiel A; Wehling M
    Eur J Clin Pharmacol; 2018 Mar; 74(3):339-347. PubMed ID: 29196825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014).
    Oelke M; Becher K; Castro-Diaz D; Chartier-Kastler E; Kirby M; Wagg A; Wehling M
    Age Ageing; 2015 Sep; 44(5):745-55. PubMed ID: 26104505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of MyFORTA: An Automated Tool to Improve Medications in Older People Based on the FORTA List.
    Wehling M; Weindrich J; Weiss C; Heser K; Pabst A; Luppa M; Bickel H; Weyerer S; Pentzek M; König HH; Lühmann D; van der Leeden C; Scherer M; Riedel-Heller SG; Wagner M; Pazan F
    Drugs Aging; 2024 Jun; 41(6):555-564. PubMed ID: 38848020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of "Fit fOR The Aged" (FORTA) on pharmacotherapy and clinical endpoints--a pilot randomized controlled study.
    Michalek C; Wehling M; Schlitzer J; Frohnhofen H
    Eur J Clin Pharmacol; 2014 Oct; 70(10):1261-7. PubMed ID: 25128076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of FORTA, PRISCUS and EU(7)-PIM lists on identifying potentially inappropriate medication and its impact on cognitive function in multimorbid elderly German people in primary care: a multicentre observational study.
    Krüger C; Schäfer I; van den Bussche H; Bickel H; Dreischulte T; Fuchs A; König HH; Maier W; Mergenthal K; Riedel-Heller SG; Schön G; Weyerer S; Wiese B; von Renteln-Kruse W; Langebrake C; Scherer M
    BMJ Open; 2021 Sep; 11(9):e050344. PubMed ID: 34535481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to Use the FORTA ("Fit fOR The Aged") List to Improve Pharmacotherapy in the Elderly.
    Wehling M
    Drug Res (Stuttg); 2016 Feb; 66(2):57-62. PubMed ID: 26198035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polypharmacy in the elderly - choosing wisely by using the FORTA list].
    Wehling M; Throm C
    Dtsch Med Wochenschr; 2015 Sep; 140(18):1378-82. PubMed ID: 26360952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug safety profiles in geriatric patients with Parkinson's disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis.
    Greten S; Müller-Funogea JI; Wegner F; Höglinger GU; Simon N; Junius-Walker U; Gerbel S; Krause O; Klietz M
    J Neural Transm (Vienna); 2021 Jan; 128(1):49-60. PubMed ID: 33263172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.